Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Post-Test and Evaluation for Child & Adolescent Psychopharmacology News 22(4)

Post-Test and Evaluation for Child & Adolescent Psychopharmacology News 22(4) CME To earn CME credit, you must read the designated article (page 1) in this issue of CAPN 22(4), 2017 and complete the quiz below, answering at least four of the questions correctly. Fax the completed page to Medical Education Resources, Inc.; Meridian One, 9785 S. Maroon Circle, Ste. 100, Englewood, CO 80112; Fax: 720-449-0217. Only the first entry will be considered for credit and must be received by MER by June 30, 2019. Acknowledgment will be sent to you within six weeks of participation. TM Medical Education Resources designates this educational activity for a maximum of 1 AMA PRA Category 1 credit. Physicians should only claim credit commensurate with the extent of their participation in the activity. Release Date: 6/18 Expiration Date: 6/19 CME Questions for Medical Marijuana in Children and Adolescents: An Updated Review for Psychopharmacologists by Shane Shucheng Wong, M.D., and Timothy E. Wilens, M.D. Educational objectives are listed on page 1. Please identify your answer by circling the appropriate letter that corresponds to your response. 1. How does THC (tetrahydrocannabinol) and CBD (cannabidiol) affect cannabinoid receptors? a. THC is a partial agonist, while CBD is an indirect c. THC and CBD are both antagonists. antagonist. b. THC and CBD are both agonists d. THC is a full agonist, while CBD is a full antagonist. 2. Which cannabinoid medications are currently approved by the FDA as prescription medications? a. Dronabinol and nabilone c. Cannabidiol b. Nabiximols d. None 3. Randomized controlled trials have shown THC to be beneficial for which medical condition in children? a. Chemotherapy-induced nausea and vomiting c. Spasticity b. Seizures d. Neuropathic pain 4. Randomized controlled trials have shown CBD to be beneficial for which medical condition in children? a. Chemotherapy-induced nausea and vomiting c. Spasticity b. Seizures d. Neuropathic pain 5. Among the below adverse side effects reported in randomized controlled trials of THC, which side effect is most commonly reported? a. Drowsiness c. Decreased appetite b. Dizziness d. Anxiety First Name Last Name Degree Hospital/Office/University Street Address City State Zip Phone E-mail Signature Your evaluation of the CME article will help guide future planning and provide necessary outcomes. Please respond to the following questions by circling your answer. For Physicians Only I certify my actual time spent to complete this educational activity to be: ____ hrs ____ mins ____ I participated in the entire activity and claim [1] credit. ____ I participated in only part of the activity and claim ____ credits. On a scale of 1–5, with five being the highest, evaluate the effectiveness of the CME Content: 1. Enhanced my current knowledge base and will help me improve patient care 5 4 3 2 1 2. Provided new ideas or information I expect to use 5 4 3 2 1 3. Information was relevant to my practice and my educational needs 5 4 3 2 1 4. This activity was designed to help the participant master the ABMS/ACGME core competencies of patient care and medical knowledge. How well did this activity address these competencies? 5 4 3 2 1 5. Were the educational objectives met? EO 1 yes ____ no ____ EO 2 yes ____ no____ 6. Please indicate any changes you plan to make in your practice of medicine as a result of information you received from this activity. _______________________________________________________________________________________________________________________________________ Rate your commitment level to making these changes. 5 4 3 2 1 In what time frame do you anticipate making these changes?  Immediately  1–2 months  3–6 months  At some point in the future 7. Was the activity free of bias for or against any commercial products? yes ____ no ____ If No, please indicate the topic(s) that were not free from commercial bias. ____________________________________________________________________________ 8. To aid in future planning, please state one or two topics you would like to see addressed in future issues. ___________________________________________________ CAPN 22(4) • 9 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Child and Adolescent Psychopharmacology News Guilford Press

Post-Test and Evaluation for Child & Adolescent Psychopharmacology News 22(4)

Child and Adolescent Psychopharmacology News , Volume 22 (4): 1 – Aug 1, 2017
Download PDF
1 page

Loading next page...
 
/lp/guilford/post-test-and-evaluation-for-child-adolescent-psychopharmacology-news-G0Q2k1YoKD

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Guilford Press
Copyright
Copyright © The Guilford Press
ISSN
1085-0295
DOI
10.1521/capn.2017.22.4.9
Publisher site
See Article on Publisher Site

Abstract

CME To earn CME credit, you must read the designated article (page 1) in this issue of CAPN 22(4), 2017 and complete the quiz below, answering at least four of the questions correctly. Fax the completed page to Medical Education Resources, Inc.; Meridian One, 9785 S. Maroon Circle, Ste. 100, Englewood, CO 80112; Fax: 720-449-0217. Only the first entry will be considered for credit and must be received by MER by June 30, 2019. Acknowledgment will be sent to you within six weeks of participation. TM Medical Education Resources designates this educational activity for a maximum of 1 AMA PRA Category 1 credit. Physicians should only claim credit commensurate with the extent of their participation in the activity. Release Date: 6/18 Expiration Date: 6/19 CME Questions for Medical Marijuana in Children and Adolescents: An Updated Review for Psychopharmacologists by Shane Shucheng Wong, M.D., and Timothy E. Wilens, M.D. Educational objectives are listed on page 1. Please identify your answer by circling the appropriate letter that corresponds to your response. 1. How does THC (tetrahydrocannabinol) and CBD (cannabidiol) affect cannabinoid receptors? a. THC is a partial agonist, while CBD is an indirect c. THC and CBD are both antagonists. antagonist. b. THC and CBD are both agonists d. THC is a full agonist, while CBD is a full antagonist. 2. Which cannabinoid medications are currently approved by the FDA as prescription medications? a. Dronabinol and nabilone c. Cannabidiol b. Nabiximols d. None 3. Randomized controlled trials have shown THC to be beneficial for which medical condition in children? a. Chemotherapy-induced nausea and vomiting c. Spasticity b. Seizures d. Neuropathic pain 4. Randomized controlled trials have shown CBD to be beneficial for which medical condition in children? a. Chemotherapy-induced nausea and vomiting c. Spasticity b. Seizures d. Neuropathic pain 5. Among the below adverse side effects reported in randomized controlled trials of THC, which side effect is most commonly reported? a. Drowsiness c. Decreased appetite b. Dizziness d. Anxiety First Name Last Name Degree Hospital/Office/University Street Address City State Zip Phone E-mail Signature Your evaluation of the CME article will help guide future planning and provide necessary outcomes. Please respond to the following questions by circling your answer. For Physicians Only I certify my actual time spent to complete this educational activity to be: ____ hrs ____ mins ____ I participated in the entire activity and claim [1] credit. ____ I participated in only part of the activity and claim ____ credits. On a scale of 1–5, with five being the highest, evaluate the effectiveness of the CME Content: 1. Enhanced my current knowledge base and will help me improve patient care 5 4 3 2 1 2. Provided new ideas or information I expect to use 5 4 3 2 1 3. Information was relevant to my practice and my educational needs 5 4 3 2 1 4. This activity was designed to help the participant master the ABMS/ACGME core competencies of patient care and medical knowledge. How well did this activity address these competencies? 5 4 3 2 1 5. Were the educational objectives met? EO 1 yes ____ no ____ EO 2 yes ____ no____ 6. Please indicate any changes you plan to make in your practice of medicine as a result of information you received from this activity. _______________________________________________________________________________________________________________________________________ Rate your commitment level to making these changes. 5 4 3 2 1 In what time frame do you anticipate making these changes?  Immediately  1–2 months  3–6 months  At some point in the future 7. Was the activity free of bias for or against any commercial products? yes ____ no ____ If No, please indicate the topic(s) that were not free from commercial bias. ____________________________________________________________________________ 8. To aid in future planning, please state one or two topics you would like to see addressed in future issues. ___________________________________________________ CAPN 22(4) • 9

Journal

Child and Adolescent Psychopharmacology News – Guilford Press

Published: Aug 1, 2017

There are no references for this article.